← UnitedHealth Group Incorporated
P/E Ratio
Price-to-earnings ratio, a valuation metric.
Latest P/E Ratio: 20.4 (2026Q1); -4.9% YoY; +2.0% CAGR since 2015Q1 (11y).
Chart and table show the latest 24 of 45 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly P/E Ratio Data
Chart and table show the latest 24 of 45 quarters.
| Period | Value |
|---|---|
| 2020Q2 | 15.2 |
| 2020Q3 | 16.4 |
| 2020Q4 | 20.2 |
| 2021Q1 | 19.6 |
| 2021Q2 | 24.6 |
| 2021Q3 | 22.6 |
| 2021Q4 | 26.0 |
| 2022Q1 | 26.2 |
| 2022Q2 | 25.2 |
| 2022Q3 | 23.3 |
| 2022Q4 | 23.7 |
| 2023Q1 | 20.5 |
| 2023Q2 | 20.5 |
| 2023Q3 | 21.0 |
| 2023Q4 | 21.2 |
| 2024Q1 | 29.2 |
| 2024Q2 | 32.7 |
| 2024Q3 | 37.0 |
| 2024Q4 | 31.9 |
| 2025Q1 | 21.5 |
| 2025Q2 | 13.3 |
| 2025Q3 | 17.9 |
| 2025Q4 | 25.0 |
| 2026Q1 | 20.4 |
Healthcare Comparison
1 / 3
Other UNH Charts
More quarter-by-quarter fundamentals for UnitedHealth Group Incorporated
1 / 8